Switzerland-based FORTY51 Ventures has announced the first close of FORTY51 Ventures I at US$43m. FORTY51 has a core strategy focused on company formation and early-stage investments in biotech mainly in Switzerland, France and Germany….
Switzerland-based FORTY51 Ventures has announced the first close of FORTY51 Ventures I at US$43m. FORTY51 has a core strategy focused on company formation and early-stage investments in biotech mainly in Switzerland, France and Germany….
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference